ImmunoPrecise Antibodies

ImmunoPrecise Antibodies
#3204 – 4464 Markham Street, V8Z 7X8
Victoria, British Columbia
CanadaPhone: 250.483.0308
Fax: 250.483.0309

ImmunoPrecise Antibodies Ltd (IPA) is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program- platforms that blend seamlessly with IPA’s Artemis Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional algorithmic outputs in therapeutic optimization, stability, affinity and manufacturability.

IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. With over 30 years of experience in the custom antibody business, we have completed roughly 4000 projects for hundreds of clients globally, including a majority of the top 20 largest pharmaceutical companies. We provide high customer satisfaction through a customized, professional approach.

Our discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and Victoria, British Columbia (IPA Canada) with headquarters located in Fargo, North Dakota. We operate globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success.

We are comprised of experienced research and development scientists that encompass a wide range of distinctive competencies, including innovative technologies required in the production of monoclonal and polyclonal antibodies. We pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving very thorough and professional service. We customize your project to generate antibodies that meet your specific needs.